FMC Treats First Patient in National Research Study

Vascular surgeons Krishna Mannava, M.D., and Omar Al-Nouri, D.O., of Fairfield Healthcare Professionals Vascular Surgery, have enrolled and treated the first patient in a national research study for the repair of abdominal aortic aneurysms.

Krishna Mannava, M.D., and Omar Al-Nouri, D.OFairfield Medical Center is one of 45 sites in the United States to participate in The LUCY Study, which is led by TriVascular Technologies, Inc. out of Santa Rosa, CA. TriVascular is the manufacturer of the Ovation® Abdominal Stent Graft Platform, an FDA-approved system to treat patients with abdominal aortic aneurysms. The 225 female and male patients enrolled in The LUCY Study undergo a minimally invasive procedure called endovascular repair, or EVAR, using the Ovation Abdominal Stent Graft System.

“Our first LUCY case went well and we are excited to continue enrolling and, ultimately, see the results from this landmark study,” said Dr. Mannava, who presented the case to fellow LUCY study investigators in Chicago last week.

The goal of The LUCY Study is to provide information about the benefits of endovascular repair in females, who in the past have been underrepresented in EVAR clinical trials, as well as compare male and female patient outcomes.

An abdominal aortic aneurysm is caused when the aortic wall weakens due to age, disease or other conditions. If left untreated, the aorta can rupture or burst, which may lead to serious internal bleeding and even death. Surgical or endovascular repair is commonly recommended by physicians to treat this condition. While abdominal aortic aneurysms are more common in men, women with this condition tend to have their aorta expand faster and potentially rupture at smaller diameter, making the problem more difficult to treat.

"We are focused on developing products and providing clinical evidence to help expand EVAR access to more patients, and improve EVAR outcomes for all patients," said Christopher G. Chavez, Chairman, CEO and President of TriVascular. "The goal of the LUCY Study is to answer very important questions and ensure that gender does not limit access to life-saving technology. We are excited to begin enrollment and are grateful to all of the study investigators who put their trust in our technology when caring for their patients." 

The LUCY Study stands for TriVascular Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair. The study name was inspired by Lucille Ball, who died from a ruptured abdominal aorta.

Tags: Vascular, Mannava, Al-Nouri, FHP, Fairfield Healthcare Professionals Vascular Surgery,